Immunologic responses to pneumonia

American Journal of Surgery

Volumn 179, Issue 2 SUPPL. 1, 2000, Pages 41-44

  Polk Jr , Hiram C ^a   Naziri, Wade ^a   McCurry Jr , Terry M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

COMPLEMENT ACTIVATION; CONFERENCE PAPER; CRITICAL ILLNESS; HUMAN; IMMUNE RESPONSE; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LUNG INFECTION; LUNG PARENCHYMA; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURGICAL PATIENT;

EID: 0343183088     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00312-3     Document Type: Conference Paper

References (28)

1. Barie P.S. Organ-specific support in multiple organ failure pulmonary support . World J Surg. 19:1995;581-591.
2. Masiakos P.T., Islam S., Doody D.P., et al. Extracorporeal membrane oxygenation for nonneonatal acute respiratory failure. Arch Surg. 134:1999;375-379.
3. Croce M.A., Fabian T.C., Patton J.H. Jr, et al. Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. J Trauma. 45:1998;273-282.
4. Naziri W., Appel S., Trachtenberg L., et al. Regional and systemic immune responses in a murine model of empyema. Surg Gynecol Obstet. 177:1993;361-365.
5. Naziri W., Cheadle W.G., Pietsch J.D., et al. Pneumonia in the surgical intensive care unit immunologic keys to the silent epidemic . Ann Surg. 219:1994;632-642.
6. Rodriguez J.L., Gibbons K.J., Bitzer L.G., et al. Pneumonia incidence, risk, and outcome in injured patients . J Trauma. 31:1991;907-912.
7. Polk H.C. Jr, Heinzelmann M., Mercer-Jones M.A., et al. Pneumonia in the surgical patient. Curr Probl Surg. 34:1997;117-208.
8. Voyles C.R., Flint J.R., DeMarco T., et al. Effect of limiting post-shock pulmonary edema on mortality from bacterial pneumonia. Am Surg. 44:1978;761-764.
9. Martin L.F., Asher E.F., Casey J.M., et al. Postoperative pneumonia determinants of mortality . Arch Surg. 119:1984;379-383.
10. Jaccard C., Troillet N., Harbarth S., et al. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nonsocomial pneumonia or peritonitis. Antimicrob Agents Chemother. 42:1998;2966-2972.
11. Croce M.A., Fabian T.C., Davis K.A., et al. Early and late acute respiratory distress syndrome two distinct clinical entities . J Trauma. 46:1999;361-368.
12. Malangoni M.A., Crafton R., Mocek F.C. Pneumonia in the surgical intensive care unit factors determining successful outcome . Am J Surg. 167:1994;250-255.
13. Galandiuk S., Appel S., Pietsch J., et al. Regional cellular responses to intraperitoneal infection. Clin Exp Immunol. 89:1992;390-394.
14. Galandiuk S., Appel S.H., Polk H.C. Jr. A biologic basis for altered host defenses in surgically infected abscesses. Ann Surg. 217:1993;624-633.
15. Mavroudis C., Ganzel B.L., Cox S.K., et al. Experimental aerobic-anaerobic thoracic empyema in the guinea pig. Ann Thorac Surg. 43:1987;289-302.
16. Polk H.C. Jr, Livingston D.H., Fry D.E., et al. Treatment of pneumonia in mechanically ventilated trauma patients. Arch Surg. 132:1997;1086-1092.
17. Rodriquez J.L., Miller C.G., DeForge L.E., et al. Local production of interleukin-8 is associated with nosocomial pneumonia. J Trauma. 34:1992;74-82.
18. Niederman M.S., Ahmed Q.A. Inflammation in severe pneumonia act locally, not globally . Crit Care Med. 27:1999;2030-2032.
19. Yoshidome H., Lentsch A.B., Cheadle W.G., et al. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced ling injury in mice. J Surg Res. 81:1999;33-37.
20. Czermak B.J., Lentsch A.B., Bless N.M., et al. Role of complement in vitro and in vivo lung inflammatory reactions. J Leukoc Biol. 64:1998;40-48.
21. Hadjiminas D.J., McMasters K.M., Peyton J.C., et al. Passive immunization against TNF and IL-1 fails to reduce lung neutrophil sequestration in chronic sepsis. Shock. 2:1994;376-380.
22. Sorensen V.J., Horst H.N., Obeid F.N., Bivens B.A. Endotracheal aminoglycosides in gram negative pneumonia a preliminary report . Am Surg. 52:1986;391-394.
23. Hashimoto S., Wolfe E., Guglielmo B., et al. Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury. J Antimicrob Chemother. 38:1996;809-818.
24. Naziri W., Cheadle W.G., Trachtenberg L.S., et al. Increased antibiotic effectiveness in a model of surgical infection through continuous infusion. Am Surg. 61:1995;11-15.
25. Bowton D.L. Nosocomial pneumonia in the ICU year 2000 and beyond . Chest. 115:1999;28S-33S.
26. Kollef M.H., Vlasnik J., Sharpless, et al. Scheduled change of antibiotic classes a strategy to decrease the incidence of ventilator-associated pneumonia . Am J Respir Crit Care Med. 156:1997;1040-1048.
27. Niederman M.S. Is crop rotation of antibiotics the solution to a resistant problem in the ICU? Am J Respir Crit Care Med. 156:1997;1029-1031.
28. Gaar E., Naziri W., Cheadle W.G., et al. Improved survival in simulated surgical infection with combined cytokine, antibiotic, and immunostimulant therapy. Br J Surg. 84:1994;1309-1311.